← Browse by Condition
Medical Condition
hepatocellular carcinoma non resectable
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2
NCT06375486 Phase 2
Recruiting
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.
Enrollment
30 pts
Location
China
Sponsor
Tianjin Medical University Can...
NCT04224636 Phase 2
Recruiting
Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab
Enrollment
106 pts
Location
Germany
Sponsor
Ludwig-Maximilians - Universit...
NCT06397222 Phase 2
Recruiting
Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCC
Enrollment
23 pts
Location
China
Sponsor
Second Affiliated Hospital of ...